EMBL Australia

An EMBL Australia group leader has co-developed a powerful 3D-printed microscope, making it widely available so researchers can easily harness this powerful technology.

Six EMBL Australia group leaders have been awarded more than $4.3 million in funding for their innovative research through the National Health and Medical Research Council (NHMRC)’s Ideas Grant scheme.

EMBL Australia group leader Dr Harald Janovjak has been awarded a $600,000 ARC Discovery Projects Grant for research that will expand our ability to manipulate nerve cell function with high specificity and without side effects.

Dr Senthil Arumugam recently joined EMBL Australia as a group leader, based at the Monash Biomedicine Discovery Institute.

An international team of scientists, led by EMBL Australia group leader Associate Professor Mikaël Martino, has cleared the way for the use of growth factors to promote tissue repair by improving the delivery system of the molecules, busting cancer side effects and potentially slashing costs.

Researchers from around the world – including a group from our Partner Laboratory Network – gathered by the sea in sunny Barcelona for the 3rd EMBL Partnership Conference, which aimed to foster collaboration within the wider EMBL network.

EMBL Australia group leader Associate Professor Max Cryle will lead the Victorian node of the new ARC Centre of Excellence for innovations in Peptide and Protein Science.

EMBL Australia Group Leaders participated in research talks, discussions and networking at the latest EMBL alumni event that was held in Brisbane.

Max Cryle and his team have revealed a novel mechanism in glycopeptide antibiotics (GPA) biosynthesis that may help in the development of new antibiotics. Their findings were published in Chemical Science.

Dr Martino has been awarded an NHMRC Investigator Grant to develop new regenerative strategies. He aims to reveal how the immune system influences the repair and regeneration of different tissues and organs, such as the heart and the lung.